Skip to main content

Table 1 Demographic data of cases and controls and clinical data of cases

From: Sleep quality among psoriasis patients: excluding the immunosuppressive therapy effect

 

Cases

Controls

Pvalue

Count

%

Count

%

Sex

Males

51

51.0%

16

20.0%

<0.001

Females

49

49.0%

64

80.0%

Marital status

Single

34

34.0%

8

10.0%

< 0.001

Married

66

66.0%

72

90.0%

Work

Working

37

37.0%

30

37.5%

0.956

Not working

63

63.0%

50

62.5%

 

Cases

Controls

Pvalue

Mean

SD

Median

Min.

Max.

Mean

SD

Median

Min.

Max.

Age

36.45

13.99

35.00

14.00

73.00

39.79

10.40

39.50

22.00

60.00

0.060

PASI

4.97

5.24

3.65

0.20

40.00

.

.

.

.

.

-----

BSA (%)

9.98

12.32

5.00

1.00

70.00

.

.

.

.

.

-----

Psoriasis duration in months

77.45

81.67

54.00

1.00

504.00

      

BMI

27.49

7.01

26.20

16.60

48.80

.

.

.

.

.

-----

PDI

13.50

11.06

10.00

0.00

51.00

.

.

.

.

.

-----

  1. PASI psoriasis area and severity index, BSA body surface area, BMI body mass index, PDI Psoriasis Disability Index